New Eye Drop Formulation Based on Desonide and Xanthan Gum in Dry Eye Disease: Nonclinical Studies

<b>Background/Objectives:</b> A novel ophthalmic formulation, XanterDES, containing 0.2% xanthan gum and 0.025% desonide sodium phosphate (DES), was developed to alleviate ocular surface discomfort and irritation. This study aimed to evaluate its pharmacodynamic properties and to charact...

Full description

Bibliographic Details
Published in:Pharmaceutics
Main Authors: Santa Viola, Luca Rosario La Rosa, Giuseppe De Pasquale, Manuela Santonocito, Donato Spina, Ilenia Abbate, Francesco Giuliano, Maria Cristina Curatolo, Maria Grazia Mazzone, Cristina Zappulla
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Subjects:
Online Access:https://www.mdpi.com/1999-4923/17/2/235